International, Peer Reviewed, Open Access Journal

Cancer Clinics Journal
(ISSN: 2689-9566)

Submit Manuscript

Cancer Clinics Journal

Cancer Clinics Journal (ISSN: 2689-9566) is a peer reviewed open access journal aims to publish significant and up-to-date articles within the fields of experimental and clinical oncology including carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; epidemiology and strategies for prevention, diagnosis, treatment, and cure for cancer.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

Cancer Clinics Journal (ISSN: 2689-9566) is a peer reviewed open access journal aims to publish significant and up-to-date articles within the fields of experimental and clinical oncology including carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; epidemiology and strategies for prevention, diagnosis, treatment, and cure for cancer.

Open Access - Cancer Clinics Journal

Editorial Board

Soldano Ferrone - Cancer Clinics Journal

Soldano Ferrone

Harvard Medical School
United States

Girijesh Kumar Patel - Cancer Clinics Journal

Girijesh Kumar Patel

University of South Alabama
United States

Yongqing Liu - Cancer Clinics Journal

Yongqing Liu

University of Louisville
United States

Mohammad Aslam Khan - Cancer Clinics Journal

Mohammad Aslam Khan

University of South Alabama-Mitchell Cancer Institute
United States

Maria Angelica Cortez - Cancer Clinics Journal

Maria Angelica Cortez

The University of Texas MD Anderson Cancer Center
United States

Hexin Chen - Cancer Clinics Journal

Hexin Chen

University of South Carolina
United States

Shanta M Messerli - Cancer Clinics Journal

Shanta M Messerli

Sanford Health
United States

Susana Maria Campos - Cancer Clinics Journal

Susana Maria Campos

Dana-Farber Cancer Institute
United States

Randa A. El-Zein - Cancer Clinics Journal

Randa A. El-Zein

Houston Methodist Hospital Houston
United States

Peter C. Hu - Cancer Clinics Journal

Peter C. Hu

The University of Texas MD Anderson Cancer Center
United States

Sanjeev K. Srivastava - Cancer Clinics Journal

Sanjeev K. Srivastava

University of South Alabama
United States

Giuliano Di Pietro - Cancer Clinics Journal

Giuliano Di Pietro

Department of Cancer Epidemiology , H Lee Moffitt Cancer Center, Tampa
United States

Our Journal Indexed in

Articles

Cancer Clin J. 2024;3(2):CCJ -03-1021 | Open Access

Effects of Decalcification Protocols on Thyroid Cancer Immunohistochemistry

Eman H Khalifa*

Background: The following study aimed to assess the effect of various decalcification methods, involving EDTA and formic acid, on the preservation and identification of important thyroid markers Thyroid Transcription Factor (TTF-1) and Thyroglobulin (TG) through Immunohistochemistry (IHC). Methods: A retrospective study involved patients with Thyroid Cancer (TC) managed in privet hospitals in the Republic of the Sudan. Results: TTF-1 IHC ... Read more

RESEARCH ARTICLE Updated Oct 09, 2024   PDF

Cancer Clin J. 2024;3(2):CCJ -03-1020 | Open Access

A Case of Duodenal-Type Follicular Lymphoma

Ximei Ren, Qibin He and Guifang Xu

A 47-year-old female patient underwent esophagogastroduodenoscopy because of intermittent abdominal pain for more than 10 years. The patient has a history of hepatitis B. No obvious abnormality was found in physical examination and laboratory examination. Gastroscopy revealed multiple small white nodular lesions in the descending part of the duodenum, with no apparent abnormalities of the nipple. Read more

IMAGE ARTICLE Updated Aug 20, 2024   PDF

Cancer Clin J. 2024;3(2):CCJ -03-1019 | Open Access

29 Years of Experience in Juvenile Myelomonocytic Leukemia and Myelodysplastic Syndrome: Retrospective Analysis of 54 Pediatric Patients

Caleffi MF, Neves VC, Dumke CCK, Watanabe FM, Trennepohl JP, Lima ACM, Nichele S, Lopes LF, Bonfim CMS and Pianovski MAD

Juvenile Myelomonocytic Leukemia (JMML) and Myelodysplastic Syndrome (MDS) are rare diseases in children. Both may progress to Acute Myeloid Leukemia which is associated with worse outcomes and a decrease in overall survival. The only curative therapy for these diseases is hematopoietic stem cell transplantation. Objective: To analyze aspects of the clinical and laboratory presentation, treatment, and survival among 54 patients diagnosed ... Read more

RESEARCH ARTICLE Updated Aug 19, 2024   PDF

Cancer Clin J. 2024;3(2):CCJ -03-1018 | Open Access

Uncovering the Gaps of Palliative Care in Pakistan

Hadia Manal, Abdullah Bin Faisal, Rafay Salman and Muhammad Atif Waqar

Palliative Care (PC) is a form of healthcare that aims to improve quality of life of patients suffering from chronic, life-threatening illnesses by early detection of disease, efforts to reduce pain and provision of holistic treatment by considering social, emotional, psychological, and spiritual perspectives. It entails a comprehensive, multi-disciplinary approach, mobilizing a team of healthcare professionals, such as physicians, nurses, ... Read more

EDITORIAL Updated Jun 05, 2024   PDF

Cancer Clin J. 2023;3(1):CCJ -03-1017 | Open Access

Evolving Novel Drug Targets For Type 2 Diabetes: A Mechanistic Approach towards - Success, Challenges and Opportunities

Piyush Vatsha, Arnab Goswami, Anjan Mondal, Arijit Mondal, Biplabkumar Chakra, Sachitra Kumar Ratha Suddhasatya Dey, Jiyaur Rahaman and Padma Charan Behera

The medications that are currently used to treat type 2 diabetes mellitus have significant drawbacks. Despite the development of new types of medications and targets, the global diabetic problem has not subsided. The search for fresh leads in routine trials continues to be significantly impacted by persistent unmet patient needs. The methods used to identify new drugs in this field have ... Read more

REVIEW ARTICLE Updated Oct 23, 2023   PDF